Metraipolis › archive › dc_dfe65cc42a36
Mechanisms and Therapeutic Advances of PXR in Metabolic Diseases and Cancer — Europe PMC PMID:40869350
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40869350
- DOI
- 10.3390/ijms26168029
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T11:54:34.571Z
- SHA-256 of the archived text
0a541567593fcabb61e4d2634f06cc790debd8a404b87993d664885e9ca49d0c- Stable URL of this page
https://metraipolis.com/documento/dc_dfe65cc42a36
How to cite
Mechanisms and Therapeutic Advances of PXR in Metabolic Diseases and Cancer — Europe PMC PMID:40869350 — Europe PMC (en), https://europepmc.org/article/MED/40869350 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dfe65cc42a36 (Metraipolis archive dc_dfe65cc42a36, sha256 0a541567593fcabb61e4d2634f06cc790debd8a404b87993d664885e9ca49d0c)
BibTeX
@misc{dcdfe65cc42a36,
title = {Mechanisms and Therapeutic Advances of PXR in Metabolic Diseases and Cancer — Europe PMC PMID:40869350},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40869350},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dfe65cc42a36; sha256 0a541567593fcabb61e4d2634f06cc790debd8a404b87993d664885e9ca49d0c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40869350. Agents can read the archived copy with the MCP tool read_document.